Hu Jin, Xu Xia, Wang Shuntao, Dong Fang, Zhang Ximeng, Ming Jie, Huang Tao
Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Oncol. 2022 May 6;12:896942. doi: 10.3389/fonc.2022.896942. eCollection 2022.
Endoscopic thyroidectomy is widely accepted for its advantages. However, implant metastasis remains a significant complication of endoscopic thyroidectomy.
This is the first report of breast implantation diagnosed with poorly differentiated thyroid carcinoma following endoscopic thyroidectomy.
We present a case of a 35-year-old woman who was initially diagnosed with a 3.0 cm conventional papillary thyroid carcinoma after endoscopic thyroidectomy total areola. Two years later, she was reported to have recurring poorly differentiated thyroid carcinoma in the right areola. Implantation after endoscopic thyroidectomy is rare, and even rarer is dedifferentiated papillary thyroid carcinoma around the implant site.
Stringently evaluated endoscopic surgery indications, appropriate preoperative evaluation, meticulous surgical technique, and adequate protective measures can significantly reduce the incidence of local implantation or recurrence.
内镜甲状腺切除术因其优势而被广泛接受。然而,种植转移仍是内镜甲状腺切除术的一个重大并发症。
这是首例内镜甲状腺切除术后诊断为低分化甲状腺癌的乳腺种植病例报告。
我们报告一例35岁女性,在内镜甲状腺全乳晕切除术后最初被诊断为3.0 cm传统乳头状甲状腺癌。两年后,她被报告右侧乳晕出现复发性低分化甲状腺癌。内镜甲状腺切除术后种植罕见,种植部位周围出现去分化乳头状甲状腺癌更为罕见。
严格评估内镜手术适应证、进行适当的术前评估、采用精细的手术技术以及采取充分的保护措施可显著降低局部种植或复发的发生率。